| Primary |
| Hepatitis C |
73.2% |
| Chronic Hepatitis C |
23.2% |
| Product Used For Unknown Indication |
0.7% |
| Hypertension |
0.5% |
| Adverse Event |
0.4% |
| Hiv Infection |
0.3% |
| Depression |
0.2% |
| Diabetes Mellitus |
0.2% |
| Prophylaxis |
0.2% |
| Rash |
0.1% |
| Anxiety |
0.1% |
| Anaemia |
0.1% |
| Insomnia |
0.1% |
| Pruritus |
0.1% |
| Pain |
0.1% |
| Nausea |
0.1% |
| Gastrooesophageal Reflux Disease |
0.1% |
| Hypothyroidism |
0.1% |
| Hepatitis |
0.1% |
| Hyperuricaemia |
0.0% |
|
| White Blood Cell Count Decreased |
19.0% |
| Rash |
16.8% |
| Vomiting |
7.9% |
| Weight Decreased |
7.2% |
| Pruritus |
5.5% |
| Nausea |
5.3% |
| Neutrophil Count Decreased |
5.0% |
| Fatigue |
4.9% |
| Drug Ineffective |
3.5% |
| Rash Pruritic |
3.4% |
| Pyrexia |
3.0% |
| Renal Impairment |
2.7% |
| Retinopathy |
2.6% |
| Rash Generalised |
2.5% |
| Weight Increased |
2.4% |
| Influenza Like Illness |
2.0% |
| Anaemia |
1.9% |
| Platelet Count Decreased |
1.6% |
| Pain |
1.5% |
| Haemoglobin Decreased |
1.5% |
|
| Secondary |
| Chronic Hepatitis C |
87.7% |
| Hepatitis C |
8.1% |
| Adverse Event |
1.2% |
| Hypertension |
0.8% |
| Prophylaxis |
0.7% |
| Rash |
0.2% |
| Hiv Infection |
0.1% |
| Hypoalbuminaemia |
0.1% |
| Hyperuricaemia |
0.1% |
| Insomnia |
0.1% |
| Sepsis |
0.1% |
| Depression |
0.1% |
| Diabetes Mellitus |
0.1% |
| Hepatic Cirrhosis |
0.1% |
| Pyrexia |
0.1% |
| Anaemia |
0.0% |
| Anxiety |
0.0% |
| Ascites |
0.0% |
| Migraine |
0.0% |
| Pain |
0.0% |
|
| White Blood Cell Count Decreased |
29.3% |
| Renal Impairment |
11.8% |
| Neutrophil Count Decreased |
9.2% |
| Retinopathy |
8.3% |
| Rash |
7.0% |
| Renal Disorder |
4.4% |
| Haemoglobin Decreased |
4.0% |
| Decreased Appetite |
3.4% |
| Vomiting |
2.8% |
| Platelet Count Decreased |
2.5% |
| Malaise |
2.4% |
| Erythema Multiforme |
2.2% |
| Retinal Haemorrhage |
2.0% |
| Drug Eruption |
1.9% |
| Nausea |
1.5% |
| Renal Failure Acute |
1.5% |
| Toxic Skin Eruption |
1.5% |
| Blood Creatinine Increased |
1.4% |
| Loss Of Consciousness |
1.3% |
| Off Label Use |
1.3% |
|
| Concomitant |
| Chronic Hepatitis C |
50.0% |
| Back Pain |
25.0% |
| Diabetes Mellitus |
25.0% |
|
|
